130 related articles for article (PubMed ID: 38874670)
1. Upadacitinib for axial spondyloarthritis: a meta-analysis of efficacy and safety.
Tang H; Liu X; Zhao J; Tang Z; Zheng Z; Bai W
Clin Rheumatol; 2024 Jun; ():. PubMed ID: 38874670
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of Janus kinase inhibitors in patients with ankylosing spondylitis: A systematic review and meta-analysis.
Li S; Li F; Mao N; Wang J; Xie X
Eur J Intern Med; 2022 Aug; 102():47-53. PubMed ID: 35461744
[TBL] [Abstract][Full Text] [Related]
3. Effect of Upadacitinib on Disease Activity, Pain, Fatigue, Function, Health-Related Quality of Life and Work Productivity for Biologic Refractory Ankylosing Spondylitis.
Navarro-Compán V; Baraliakos X; Magrey M; Östör A; Saffore CD; Mittal M; Song IH; Ganz F; Stigler J; Deodhar A
Rheumatol Ther; 2023 Jun; 10(3):679-691. PubMed ID: 36820984
[TBL] [Abstract][Full Text] [Related]
4. Janus kinase inhibitors for treating active ankylosing spondylitis: a meta-analysis of randomized controlled trials.
Lee YH; Song GG
Z Rheumatol; 2022 Feb; 81(1):71-76. PubMed ID: 33340056
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1).
Sieper J; van der Heijde D; Dougados M; Mease PJ; Maksymowych WP; Brown MA; Arora V; Pangan AL
Ann Rheum Dis; 2013 Jun; 72(6):815-22. PubMed ID: 22772328
[TBL] [Abstract][Full Text] [Related]
6. Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis).
Kroon FP; van der Burg LR; Ramiro S; Landewé RB; Buchbinder R; Falzon L; van der Heijde D
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD010952. PubMed ID: 26186173
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of upadacitinib in patients with ankylosing spondylitis refractory to biologic therapy: 1-year results from the open-label extension of a phase III study.
Baraliakos X; van der Heijde D; Sieper J; Inman RD; Kameda H; Li Y; Bu X; Shmagel A; Wung P; Song IH; Deodhar A
Arthritis Res Ther; 2023 Sep; 25(1):172. PubMed ID: 37723577
[TBL] [Abstract][Full Text] [Related]
8. Safety Profile of Upadacitinib up to 5 Years in Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis: An Integrated Analysis of Clinical Trials.
Burmester GR; Stigler J; Rubbert-Roth A; Tanaka Y; Azevedo VF; Coombs D; Lagunes I; Lippe R; Wung P; Gensler LS
Rheumatol Ther; 2024 Jun; 11(3):737-753. PubMed ID: 38683479
[TBL] [Abstract][Full Text] [Related]
9. The Discriminative Values of the Bath Ankylosing Spondylitis Disease Activity Index, Ankylosing Spondylitis Disease Activity Score, C-Reactive Protein, and Erythrocyte Sedimentation Rate in Spondyloarthritis-Related Axial Arthritis.
Tsang HHL; Chung HY
J Clin Rheumatol; 2017 Aug; 23(5):267-272. PubMed ID: 28661926
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of upadacitinib in patients with active psoriatic arthritis and axial involvement: results from two phase 3 studies.
Baraliakos X; Ranza R; Östör A; Ciccia F; Coates LC; Rednic S; Walsh JA; Douglas K; Gao T; Kato K; Song IH; Ganz F; Deodhar A
Arthritis Res Ther; 2023 Apr; 25(1):56. PubMed ID: 37038159
[TBL] [Abstract][Full Text] [Related]
11. Clinimetric properties of the ASAS health index in a cohort of Italian patients with axial spondyloarthritis.
Di Carlo M; Lato V; Carotti M; Salaffi F
Health Qual Life Outcomes; 2016 May; 14():78. PubMed ID: 27188166
[TBL] [Abstract][Full Text] [Related]
12. Procollagen I N-terminal peptide correlates with inflammation on sacroiliac joint magnetic resonance imaging in ankylosing spondylitis but not in non-radiographic axial spondyloarthritis: A cross-sectional study.
Li X; Liang A; Chen Y; Lam NS; Long X; Xu X; Zhong S
Mod Rheumatol; 2022 Jul; 32(4):770-775. PubMed ID: 34897520
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy: a double-blind, randomised, placebo-controlled phase 3 trial.
van der Heijde D; Baraliakos X; Sieper J; Deodhar A; Inman RD; Kameda H; Zeng X; Sui Y; Bu X; Pangan AL; Wung P; Song IH
Ann Rheum Dis; 2022 Nov; 81(11):1515-1523. PubMed ID: 35788492
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Ankylosing Spondylitis Disease Activity Score and Bath Ankylosing Spondylitis Disease Activity Index tools in assessment of axial spondyloarthritis activity.
Wiąk-Walerowicz K; Wielosz E
Reumatologia; 2024; 62(1):64-69. PubMed ID: 38558891
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and Safety of Wenbu Zhibi Granule in Patients with Ankylosing Spondylitis: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial.
Zhang H; Yu Y; Du W; Wu F; Zheng Y; Ren C; Zhou H; Wu Y; Gao Y; Ren W; Quan R
Evid Based Complement Alternat Med; 2021; 2021():8683600. PubMed ID: 34868333
[No Abstract] [Full Text] [Related]
16. 5-year efficacy and safety of secukinumab in patients with ankylosing spondylitis: end-of-study results from the phase 3 MEASURE 2 trial.
Marzo-Ortega H; Sieper J; Kivitz AJ; Blanco R; Cohen M; Pavelka K; Delicha EM; Stefanska A; Richards HB; Rohrer S
Lancet Rheumatol; 2020 Jun; 2(6):e339-e346. PubMed ID: 38273597
[TBL] [Abstract][Full Text] [Related]
17. Physical function and sex differences in radiographic axial spondyloarthritis: a cross-sectional analysis on Bath Ankylosing Spondylitis Functional Index.
Hallström M; Klingberg E; Deminger A; Rehnman JB; Geijer M; Forsblad-d'Elia H
Arthritis Res Ther; 2023 Sep; 25(1):182. PubMed ID: 37749599
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the clinical characteristics and quality of life of male and female patients with non-radiographic axial spondyloarthritis.
Unal Enginar A
Int Immunopharmacol; 2023 Oct; 123():110627. PubMed ID: 37494835
[TBL] [Abstract][Full Text] [Related]
19. Clinimetric Validation of the Assessment of Spondyloarthritis International Society Health Index in Patients With Radiographic Axial Spondyloarthritis in Ixekizumab Trials.
Kiltz U; van der Heijde D; Boonen A; Gensler LS; Gibble TH; Guo J; Carlier H; Braun J
J Rheumatol; 2023 Jun; 50(6):754-762. PubMed ID: 36725056
[TBL] [Abstract][Full Text] [Related]
20. Discriminant validity, responsiveness and reliability of the arthritis-specific Work Productivity Survey assessing workplace and household productivity within and outside the home in patients with axial spondyloarthritis, including nonradiographic axial spondyloarthritis and ankylosing spondylitis.
Osterhaus JT; Purcaru O
Arthritis Res Ther; 2014 Aug; 16(4):R164. PubMed ID: 25099160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
